1. Jeong TH, Kim CY, Sa KJ, et al. The effect of hormone replacement therapy and related factors on the change of bone mineral density in early postmenopausal women in Ulsan-si, Korea. J Korean Acad Fam Med 2004;25:233-243.
2. Cho S, Kim WS, Park JH, et al. The effect of hormone replacement therapy on bone mineral density in postmenopausal women. Korean J Obstet Gynecol 1998;41:475-482.
6. Lentle BC, Brown JP, Khan A, et al. Recognizing and reporting vertebral fractures: reducing the risk of future osteoporotic fractures. Can Assoc Radiol J 2007;58:27-36.
7. Burnett JR, Vasikaran SD. Cardiovascular disease and osteoporosis: is there a link between lipids and bone? Ann Clin Biochem 2002;39:203-210.
8. Brattström L, Israelsson B, Lindgärde F, et al. Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency. Metabolism 1988;37:175-178.
9. Kang SS, Zhou J, Wong PW, et al. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988;43:414-421.
10. Oh KW, Lee WY, Ahn YB, et al. Homocysteine, folate, and methylenetetrahydrofolate reductase polymorphism in Korean normal subjects. Korean J Med 1999;57:1030-1036.
11. Asfar S, Safar HA. Homocysteine levels and peripheral arterial occlusive disease: a prospective cohort study and review of the literature. J Cardiovasc Surg (Torino) 2007;48:601-605.
13. Mudd SH, Skovby F, Levy HL, et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 1985;37:1-31.
15. Koh JM, Lee YS, Kim YS, et al. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 2006;21:1003-1011.
16. Kim DJ, Koh JM, Lee O, et al. Homocysteine enhances apoptosis in human bone marrow stromal cells. Bone 2006;39:582-590.
17. Lubec B, Fang-Kircher S, Lubec T, et al. Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1996;1315:159-162.
19. McLean RR, Jacques PF, Selhub J, et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 2004;350:2042-2049.
20. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004;350:2033-2041.
21. Gjesdal CG, Vollset SE, Ueland PM, et al. Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study. Arch Intern Med 2006;166:88-94.
22. Bae SJ, Son HY, Kim DJ, et al. Lack of association between homocysteine levels and bone mineral density in healthy premenopausal and postmenopausal women. Korean J Bone Metab 2004;11:19-24.
23. Kim A, Lee JH, Lee JY, et al. Association between serum homocysteine concentrations and bone mineral density in middle aged women. J Korean Soc Menopause 2013;19:81-86.
24. Lee YJ, Lee SW, Lee HS, et al. The relationship of serum homocysteine levels with lumbar and femoral bone mineral density. Korean J Fam Med 2008;29:175-181.
26. Rasmussen K, Møller J. Total homocysteine measurement in clinical practice. Ann Clin Biochem 2000;37(Pt 5):627-648.
27. Marcus R. Role of exercise in preventing and treating osteoporosis. Rheum Dis Clin North Am 2001;27:131-141. vi
29. Baik HW, Russell RM. Vitamin B12 deficiency in the elderly. Annu Rev Nutr 1999;19:357-377.
30. Stone KL, Bauer DC, Sellmeyer D, et al. Low serum vitamin B-12 levels are associated with increased hip bone loss in older women: a prospective study. J Clin Endocrinol Metab 2004;89:1217-1221.
32. Neuhouser ML, Beresford SA. Folic acid: are current fortification levels adequate? Nutrition 2001;17:868-872.